FernandoEMembrenoMDMSc
Gastroenterology • San Antonio, TXHepatology & Liver Transplantation
CEO Starhope Liver Center, PA
Dr. Membreno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3303 Rogers Road
Suite 230
San Antonio, TX 78251Phone+1 210-469-3471Fax+1 800-355-1653
Summary
- Dr. Fernando Membreno is a gastroenterologist and Transplant Hepatologist in San Antonio, TX and is the CEO of Starhope Liver Center. He received his medical degree from Universidad de Ciencias Medicas and GI Fellowship at UTMB Galveston, has been in practice 22 years. He specializes in hepatology & liver transplantation and is experienced in clinical research trials. He has 9 publications and over 500 citings.
Education & Training
University of Texas Medical Branch HospitalsFellowship, Gastroenterology, 2000 - 2003
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 1997 - 2000
Universidad de Ciencias MedicasClass of 1995
Certifications & Licensure
TX State Medical License 2006 - 2026
CO State Medical License 2003 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.Mary E Rinella, Hsiao D Lieu, Kris V Kowdley, Zachary D Goodman, Naim Alkhouri
Hepatology. 2024-03-01 - 85 citationsSofosbuvir with peginterferon‐ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosisEric Lawitz, Fred Poordad, Diana M. Brainard, Robert H. Hyland, Di An
Hepatology. 2015-03-01 - 14 citationsResponse-guided therapy in patients with genotype 1 hepatitis C virus: current status and future prospects.Eric Lawitz, Fernando E. Membreno
Journal of Gastroenterology and Hepatology. 2014-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
